Optimal treatment duration in metastatic renal cell carcinoma patients responding to immune checkpoint inhibitors: should we treat beyond two years? - Decruyenaere, Alexander; Gennigens, Christine; Rottey, Sylvie; Laenen, Annouschka; Seront, Emmanuel; Everaert, Els; Debruyne, Philip R.; van den Bulck, Heidi; Bastin, Julie; Verbiest, Annelies; Vulsteke, Christof; Schatteman, Peter; et al. (ISSN:0284-186X ; ISSN:1651-226X ; Acta Oncologica, vol. 64 (979-988, 2025)